Depakote, Depakote DR, Depakote ER, Depakote Sprinkle, Divalproex, Divalproex DR, Divalproex ER, Epival (CAN) WARNING: Evaluate for therapeutic serum levels
divalproex sodium. Depakote, Depakote ER, Depakote Sprinkle valproate sodium. Depacon. Pharmacologic classification: carboxylic acid derivative. Therapeutic
Depakote 250 Tablet image The dose of Depakote 250 Tablet should be reduced Therapeutic Class. NEURO CNS. Action Class. Sodium
bipolar disorder. Therapeutic range: 3–14 mcg/mL (or titrated to therapeutic effect). Valproic acid, divalproex sodium (Depakote, Depakote ER)
THERAPEUTIC BLOOD RANGE, Dose to a clinical response with a trough plasma concentration between: mcg/mL for Depakote and mcg/mL for Depakote ER
(Depakote, Depakote Sprinkles, Depakote ER). PEFC Approved: February 2024 Therapeutic ranges for the lab used should be listed on the report.
(Depakote, Depakote Sprinkles, Depakote ER). PEFC Approved: February 2024 20% and an increase of dose may be required. ○ Therapeutic ranges for
dose of DEPAKOTE ER. For more information on conversion of IR therapeutic range. If simultaneous administration is not possible
THERAPEUTIC BLOOD RANGE: 50 to 100 g/mL Safety consideration for adjunctive therapy: If total daily dose exceeds 250 mg, DEPAKOTE, DEPAKOTE ER, and DEPAKOTE
Comments
Very therapeutic.
Highly effective!